{"DataElement":{"publicId":"62343","version":"5","preferredName":"Gynecologic Tumor Grouping Gynecologic Tumor Grouping Stage","preferredDefinition":"the FIGO staging criteria based on the assignment of TNM categories (AJCC 6th Ed) into groups used to select and evaluate therapy, estimate prognosis and calculate end results.","longName":"GYN_TUMOR_GP_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2190067","version":"1","preferredName":"Gynecologic Tumor Grouping","preferredDefinition":"information related to gynecologic tumor grouping.","longName":"GYN_TUMOR_GP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177523","version":"1","preferredName":"Grouping","preferredDefinition":"Grouping; a system for classifying things into groups; the activity of putting things together in groups.","longName":"Grouping","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Grouping","conceptCode":"C25523","definition":"A system for classifying things into groups or the activity of putting things together in groups.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5204-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67FFEA3-D68C-2C1F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015357","version":"4","preferredName":"Gynecologic Tumor Grouping Stage","preferredDefinition":"a classification of gynecologic cancer using the FIGO staging system; stage groups indicate type of gynecologic tumor and other disease factors.","longName":"2015357v4.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IIC","valueDescription":"IIC","ValueMeaning":{"publicId":"2568956","version":"1","preferredName":"IIC","longName":"2568956","preferredDefinition":"Stage IIC","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA69-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-31","modifiedBy":"CURTIST","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AEBE3FA-1408-A1FD-E040-BB89AD4332E5","beginDate":"2009-05-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-05-27","modifiedBy":"ONEDATA","dateModified":"2009-05-27","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"IIIC","ValueMeaning":{"publicId":"2565904","version":"1","preferredName":"IIIC","longName":"2565904v1.00","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC","conceptCode":"C27982","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE7D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-04-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-04-24","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AEBE3FA-1412-A1FD-E040-BB89AD4332E5","beginDate":"2009-05-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-05-27","modifiedBy":"ONEDATA","dateModified":"2009-05-27","deletedIndicator":"No"},{"value":"Stage I Cervical Cancer","valueDescription":"Stage I Cervical Cancer","ValueMeaning":{"publicId":"2838731","version":"1","preferredName":"Stage I Cervical Cancer","longName":"2838731","preferredDefinition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cervical Cancer AJCC v6 and v7","conceptCode":"C9204","definition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-105B-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1074-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage 0 Cervical Cancer","valueDescription":"Stage 0 Cervical Cancer","ValueMeaning":{"publicId":"2838727","version":"1","preferredName":"Stage 0 Cervical Cancer","longName":"2838727","preferredDefinition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cervical Cancer AJCC v7","conceptCode":"C89550","definition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis.  M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-100F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1028-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage II Cervical Cancer","valueDescription":"Stage II Cervical Cancer","ValueMeaning":{"publicId":"2838729","version":"1","preferredName":"Stage II Cervical Cancer","longName":"2838729","preferredDefinition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but no to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervical Cancer AJCC v7","conceptCode":"C89551","definition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1035-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-104E-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage III Cervical Cancer","valueDescription":"Stage III Cervical Cancer","ValueMeaning":{"publicId":"2838733","version":"1","preferredName":"Stage III Cervical Cancer","longName":"2838733","preferredDefinition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cervical Cancer AJCC v6 and v7","conceptCode":"C9205","definition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney.  N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1081-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-109A-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IV Cervical Cancer","valueDescription":"Stage IV Cervical Cancer","ValueMeaning":{"publicId":"2838735","version":"1","preferredName":"Stage IV Cervical Cancer","longName":"2838735","preferredDefinition":"Stage IV includes: IVA: (T4, Any N, M0); IVB (Any T, Any N, MI). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (AJCC 6th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cervical Cancer AJCC v6 and v7","conceptCode":"C9206","definition":"Stage IV includes: IVA: (T4, Any N, M0); IVB (Any T, Any N, MI). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10A7-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-10C0-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IA Cervical Cancer","valueDescription":"Stage IA Cervical Cancer","ValueMeaning":{"publicId":"2838737","version":"1","preferredName":"Stage IA Cervical Cancer","longName":"2838737v1.00","preferredDefinition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0).  T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cervical Cancer AJCC v6 and v7","conceptCode":"C6313","definition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0).  T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10CD-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-10E6-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IA1 Cervical Cancer","valueDescription":"Stage IA1 Cervical Cancer","ValueMeaning":{"publicId":"2838739","version":"1","preferredName":"Stage IA1 Cervical Cancer","longName":"2838739v1.00","preferredDefinition":"Stage IA1 includes: T1a1, N0, M0.  T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6314","definition":"Stage IA1 includes: T1a1, N0, M0.  T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10F3-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-110C-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IA2 Cervical Cancer","valueDescription":"Stage IA2 Cervical Cancer","ValueMeaning":{"publicId":"2838741","version":"1","preferredName":"Stage IA2 Cervical Cancer","longName":"2838741v1.00","preferredDefinition":"Stage IA2 includes: T1a2, N0, M0.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6315","definition":"Stage IA2 includes: T1a2, N0, M0.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1119-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1132-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IB Cervical Cancer","valueDescription":"Stage IB Cervical Cancer","ValueMeaning":{"publicId":"2838743","version":"1","preferredName":"Stage IB Cervical Cancer","longName":"2838743v1.00","preferredDefinition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervical Cancer AJCC v6 and v7","conceptCode":"C6316","definition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-113F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1158-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IB1 Cervical Cancer","valueDescription":"Stage IB1 Cervical Cancer","ValueMeaning":{"publicId":"2838745","version":"1","preferredName":"Stage IB1 Cervical Cancer","longName":"2838745v1.00","preferredDefinition":"Stage IB1 includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6317","definition":"Stage IB1 includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1165-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-117E-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IB2 Cervical Cancer","valueDescription":"Stage IB2 Cervical Cancer","ValueMeaning":{"publicId":"2838747","version":"1","preferredName":"Stage IB2 Cervical Cancer","longName":"2838747v1.00","preferredDefinition":"Stage IB2 includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6318","definition":"Stage IB2 includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-118B-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-11A4-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IIA Cervical Cancer","valueDescription":"Stage IIA Cervical Cancer","ValueMeaning":{"publicId":"2838749","version":"1","preferredName":"Stage IIA Cervical Cancer","longName":"2838749v1.00","preferredDefinition":"Tumor without parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervical Cancer AJCC v6","conceptCode":"C6319","definition":"Tumor without parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11B1-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-11CA-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IIB Cervical Cancer","valueDescription":"Stage IIB Cervical Cancer","ValueMeaning":{"publicId":"2838751","version":"1","preferredName":"Stage IIB Cervical Cancer","longName":"2838751v1.00","preferredDefinition":"Stage IIB includes: T2b, N0, M0.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6320","definition":"Stage IIB includes: T2b, N0, M0.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11D7-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-11F0-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IIIA Cervical Cancer","valueDescription":"Stage IIIA Cervical Cancer","ValueMeaning":{"publicId":"2838753","version":"1","preferredName":"Stage IIIA Cervical Cancer","longName":"2838753v1.00","preferredDefinition":"Stage IIIA includes: T3a, N0, M0.  T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cervical Cancer AJCC v6 and v7","conceptCode":"C6322","definition":"Stage IIIA includes: T3a, N0, M0.  T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11FD-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1216-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IIIB Cervical Cancer","valueDescription":"Stage IIIB Cervical Cancer","ValueMeaning":{"publicId":"2838755","version":"1","preferredName":"Stage IIIB Cervical Cancer","longName":"2838755v1.00","preferredDefinition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0).  T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6321","definition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0).  T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1223-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-123C-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IVA Cervical Cancer","valueDescription":"Stage IVA Cervical Cancer","ValueMeaning":{"publicId":"2838757","version":"1","preferredName":"Stage IVA Cervical Cancer","longName":"2838757v1.00","preferredDefinition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Cervical Cancer AJCC v6 and v7","conceptCode":"C6323","definition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1249-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1262-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Stage IVB Cervical Cancer","valueDescription":"Stage IVB Cervical Cancer","ValueMeaning":{"publicId":"2838759","version":"1","preferredName":"Stage IVB Cervical Cancer","longName":"2838759v1.00","preferredDefinition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Cervical Cancer AJCC v6 and v7","conceptCode":"C6324","definition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-126F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A85C92-1288-B23A-E040-BB89AD431D54","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Cervical Cancer","ValueMeaning":{"publicId":"2838731","version":"1","preferredName":"Stage I Cervical Cancer","longName":"2838731","preferredDefinition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cervical Cancer AJCC v6 and v7","conceptCode":"C9204","definition":"Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-105B-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0942-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Cervical Cancer","ValueMeaning":{"publicId":"2838737","version":"1","preferredName":"Stage IA Cervical Cancer","longName":"2838737v1.00","preferredDefinition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0).  T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Cervical Cancer AJCC v6 and v7","conceptCode":"C6313","definition":"Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0).  T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10CD-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0956-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Cervical Cancer","ValueMeaning":{"publicId":"2838727","version":"1","preferredName":"Stage 0 Cervical Cancer","longName":"2838727","preferredDefinition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cervical Cancer AJCC v7","conceptCode":"C89550","definition":"Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis.  M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-100F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-092E-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IA1","valueDescription":"Stage IA1 Cervical Cancer","ValueMeaning":{"publicId":"2838739","version":"1","preferredName":"Stage IA1 Cervical Cancer","longName":"2838739v1.00","preferredDefinition":"Stage IA1 includes: T1a1, N0, M0.  T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6314","definition":"Stage IA1 includes: T1a1, N0, M0.  T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10F3-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-096A-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IA2","valueDescription":"Stage IA2 Cervical Cancer","ValueMeaning":{"publicId":"2838741","version":"1","preferredName":"Stage IA2 Cervical Cancer","longName":"2838741v1.00","preferredDefinition":"Stage IA2 includes: T1a2, N0, M0.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6315","definition":"Stage IA2 includes: T1a2, N0, M0.  T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1119-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-097E-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Cervical Cancer","ValueMeaning":{"publicId":"2838743","version":"1","preferredName":"Stage IB Cervical Cancer","longName":"2838743v1.00","preferredDefinition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervical Cancer AJCC v6 and v7","conceptCode":"C6316","definition":"Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-113F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0992-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IB1","valueDescription":"Stage IB1 Cervical Cancer","ValueMeaning":{"publicId":"2838745","version":"1","preferredName":"Stage IB1 Cervical Cancer","longName":"2838745v1.00","preferredDefinition":"Stage IB1 includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1 Cervical Cancer AJCC v6 and v7","conceptCode":"C6317","definition":"Stage IB1 includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1165-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-09A6-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IB2","valueDescription":"Stage IB2 Cervical Cancer","ValueMeaning":{"publicId":"2838747","version":"1","preferredName":"Stage IB2 Cervical Cancer","longName":"2838747v1.00","preferredDefinition":"Stage IB2 includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2 Cervical Cancer AJCC v6 and v7","conceptCode":"C6318","definition":"Stage IB2 includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-118B-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-09BA-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Cervical Cancer","ValueMeaning":{"publicId":"2838729","version":"1","preferredName":"Stage II Cervical Cancer","longName":"2838729","preferredDefinition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but no to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervical Cancer AJCC v7","conceptCode":"C89551","definition":"Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1035-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-09CE-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Cervical Cancer","ValueMeaning":{"publicId":"2838749","version":"1","preferredName":"Stage IIA Cervical Cancer","longName":"2838749v1.00","preferredDefinition":"Tumor without parametrial invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervical Cancer AJCC v6","conceptCode":"C6319","definition":"Tumor without parametrial invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11B1-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-09E2-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Cervical Cancer","ValueMeaning":{"publicId":"2838751","version":"1","preferredName":"Stage IIB Cervical Cancer","longName":"2838751v1.00","preferredDefinition":"Stage IIB includes: T2b, N0, M0.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6320","definition":"Stage IIB includes: T2b, N0, M0.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11D7-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-09F6-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Cervical Cancer","ValueMeaning":{"publicId":"2838733","version":"1","preferredName":"Stage III Cervical Cancer","longName":"2838733","preferredDefinition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cervical Cancer AJCC v6 and v7","conceptCode":"C9205","definition":"Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney.  N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1081-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A0A-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Cervical Cancer","ValueMeaning":{"publicId":"2838753","version":"1","preferredName":"Stage IIIA Cervical Cancer","longName":"2838753v1.00","preferredDefinition":"Stage IIIA includes: T3a, N0, M0.  T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Cervical Cancer AJCC v6 and v7","conceptCode":"C6322","definition":"Stage IIIA includes: T3a, N0, M0.  T3a: Tumor involves lower third of vagina, no extension to pelvic wall.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-11FD-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A1E-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Cervical Cancer","ValueMeaning":{"publicId":"2838755","version":"1","preferredName":"Stage IIIB Cervical Cancer","longName":"2838755v1.00","preferredDefinition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0).  T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Cervical Cancer AJCC v6 and v7","conceptCode":"C6321","definition":"Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0).  T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1223-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A32-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Cervical Cancer","ValueMeaning":{"publicId":"2838735","version":"1","preferredName":"Stage IV Cervical Cancer","longName":"2838735","preferredDefinition":"Stage IV includes: IVA: (T4, Any N, M0); IVB (Any T, Any N, MI). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (AJCC 6th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cervical Cancer AJCC v6 and v7","conceptCode":"C9206","definition":"Stage IV includes: IVA: (T4, Any N, M0); IVB (Any T, Any N, MI). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-10A7-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A46-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Cervical Cancer","ValueMeaning":{"publicId":"2838757","version":"1","preferredName":"Stage IVA Cervical Cancer","longName":"2838757v1.00","preferredDefinition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Cervical Cancer AJCC v6 and v7","conceptCode":"C6323","definition":"Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-1249-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A5A-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Cervical Cancer","ValueMeaning":{"publicId":"2838759","version":"1","preferredName":"Stage IVB Cervical Cancer","longName":"2838759v1.00","preferredDefinition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Cervical Cancer AJCC v6 and v7","conceptCode":"C6324","definition":"Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-126F-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"62A900E9-0A6E-0775-E040-BB89AD437E02","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","deletedIndicator":"No"},{"value":"Not Available","valueDescription":"Not Available","ValueMeaning":{"publicId":"2562605","version":"1","preferredName":"Not Available","longName":"2562605","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C19A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2012-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7678650-5E85-DD6A-E040-BB89AD432A62","beginDate":"2012-08-16","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-08-16","modifiedBy":"ONEDATA","dateModified":"2012-08-16","deletedIndicator":"No"},{"value":"Persistent","valueDescription":"Persistent","ValueMeaning":{"publicId":"2567846","version":"1","preferredName":"Persistent","longName":"2567846v1.00","preferredDefinition":"Retained; never-ceasing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Persistent","conceptCode":"C43623","definition":"Retained; never-ceasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D613-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7678650-5E8F-DD6A-E040-BB89AD432A62","beginDate":"2012-08-16","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-08-16","modifiedBy":"ONEDATA","dateModified":"2012-08-16","deletedIndicator":"No"},{"value":"Recurrent","valueDescription":"Recurrent","ValueMeaning":{"publicId":"2567847","version":"1","preferredName":"Recurrent","longName":"2567847v1.00","preferredDefinition":"Occurring again.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D614-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7678650-5E99-DD6A-E040-BB89AD432A62","beginDate":"2012-08-16","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-08-16","modifiedBy":"ONEDATA","dateModified":"2012-08-16","deletedIndicator":"No"},{"value":"IIA2","valueDescription":"Stage IIA2 Cervical Cancer","ValueMeaning":{"publicId":"3431287","version":"1","preferredName":"Stage IIA2 Cervical Cancer","longName":"3431287","preferredDefinition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA2 Cervical Cancer AJCC v7","conceptCode":"C95173","definition":"Stage IIA2 includes: T2a2, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6603-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7285211-7D6A-C508-E040-BB89AD433159","beginDate":"2012-08-13","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"},{"value":"IIA1","valueDescription":"Stage IIA1 Cervical Cancer","ValueMeaning":{"publicId":"3431288","version":"1","preferredName":"Stage IIA1 Cervical Cancer","longName":"3431288","preferredDefinition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA1 Cervical Cancer AJCC v7","conceptCode":"C95172","definition":"Stage IIA1 includes: T2a1, N0, M0.  Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCDE9F64-6628-D14C-E040-BB89AD43176F","latestVersionIndicator":"Yes","beginDate":"2012-04-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7285211-7D74-C508-E040-BB89AD433159","beginDate":"2012-08-13","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-08-13","modifiedBy":"ONEDATA","dateModified":"2012-08-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A85C92-0EE8-B23A-E040-BB89AD431D54","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"REBOYJ","dateModified":"2012-08-16","changeDescription":"Updated to AJCC 6th ED.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811817","version":"1","longName":"Primary Cervical","context":"CTEP"},{"publicId":"2811818","version":"1","longName":"Primary Endometrial","context":"CTEP"},{"publicId":"2811819","version":"1","longName":"Primary Ovarian","context":"CTEP"},{"publicId":"2811934","version":"1","longName":"Pathology Gyn","context":"CTEP"},{"publicId":"2811938","version":"1","longName":"Recurrent Gyn","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"},{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104879","version":"1","longName":"GOG-0219","context":"NRG"},{"publicId":"4104996","version":"1","longName":"GOG-0279","context":"NRG"},{"publicId":"4058120","version":"1","longName":"GOG-0278","context":"NRG"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"GYN_TUMOR_GP_ST","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text2","type":"Alternate Question Text","description":"FIGO staging","url":null,"context":"CTEP"},{"name":"COMMENT_366","type":"COMMENT","description":"Instruction on template form:  (FIGO)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Stage Grouping","url":null,"context":"CTEP"},{"name":"Stage","type":"Preferred Question Text","description":"Stage","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Stage at diagnosis (FIGO 2009)","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"62A80A49-00DE-95C0-E040-BB89AD43324B","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-11","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"revised and updated for ISO compliance and replaced VD due to missing values","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}